Johan Denollet, PhD the heart failure patient ? Why is a dedicated cardiologist not sufficient for The Netherlands.

Slides:



Advertisements
Similar presentations
Depression, Vital Exhaustion and recurrent heart disease.
Advertisements

Type D, or distressed personality and CHD. A new risk factor?
Therapy-Related Cardiac Toxicity in Cancer Patients JEAN-BERNARD DURAND, M.D., FCCP, FACC ASSOCIATE PROFESSOR OF MEDICINE MEDICAL DIRECTOR CARDIOMYOPATHY.
The Importance of Beta-Blockers in Patients with Heart Failure: A Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT) Analysis.
La stratificazione del rischio aritmico oltre la frazione di eiezione Milano 17 Aprile 2009 Prof. Luigi Padeletti Heart Failure & Co.
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
Is heart failure associated with disability? European Academy for Medicine of Ageing, Martigny, January 24th 2013 Marius Myrstad.
Improving survival in symptomatic ischemic patients with left ventricular dysfunction Beneficial effects of long-term trimetazidine* therapy Fragasso G.
analysis from the SHIFT study
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
lth/student-led-film-takes-on-teen-anxiety- depression/
Fibromyalgia Research: From Neurasthenia to Central Processing Abnormalities Laurence A. Bradley, PhD Division of Clinical Immunology and Rheumatology.
By: Jerry & Nathan. Definition The bipolar disorder is when you have mood swings that range from the lows of depression to the highs of mania. These mood.
Low Adherence of Hypertension Patients to Treatment – What Is To Be Done? Clinical Problem for Public Health Alexander V. Sergeev, MD, PhD, MPH Irina B.
SECTION 7 Depression.
Emily O’Brien, Emil Fosbol, Andrew Peng, Karen Alexander, Matthew Roe, Eric Peterson The Obesity Paradox: The Importance for Long-term Outcomes in Non-ST-Elevation.
Appendix: Clinical Guidelines VBWG. I Intervention is useful and effective III Intervention is not useful or effective and may be harmful A Data derived.
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
Myocardial Ischemia Redefined: Optimal Care in CAD.
Cognitive Impairment: An Independent Predictor of Excess Mortality SACHS, CARTER, HOLTZ, ET AL. ANN INTERN MED, SEP, 2011;155: ZACHARY LAPAQUETTE.
Effect of ivabradine on recurrent hospitalization for worsening heart failure: findings from SHIFT S ystolic H eart failure treatment with the I f inhibitor.
Secondary Prevention & Cardiac Rehabilitation Malcolm Walker Consultant Cardiologist UCLH & the Heart Hospital, London.
Functional Impairment and Depressive Symptoms: Mitigating Effects of Trait Hope Jameson K. Hirsch, Ph.D. 1,2, S. Kaye, B.S. 1, & Jeffrey M. Lyness, M.D.
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Main results Swedberg K, et al. Lancet. 2010;376(9744):
The Burden and Contributors to Cardiovascular Disease and Diabetes in Indigenous Australians Alex Brown Baker IDI.
Teen Depression.  Among teens, depressive symptoms occur 8 times more often than serious depression  Duration is the key difference between depressed.
Al wakeel J, Bayoumi M, Al Ghonaim M, Al Harbi A, Al Swaida A, Mashraqy A.
Does asymptomatic patients with very frequent ventricular ectopy need prophylactic catheter ablation to prevent the development of cardiomyopathy Minglong.
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Efficacy and safety of ivabradine in patients with severe chronic systolic.
Cardiovascular disease in a large cohort of depressed and/or anxious patients Results of the Netherlands Study of Depression and Anxiety N Vogelzangs 1,
Epidemiology th August, Valencia Alcohol consumption in relation to risk (and severity) of reported chronic pain Professor Gary J Macfarlane.
New Technologies & Challenges in optimizing the “heart health” of Australia Professor Simon Stewart Head, Preventative Cardiology
Adolescent Mental Health Depression Signs. Symptoms. Consequences.
Positive and Negative Affect and Health in Lung Cancer Patients Jameson K. Hirsch, Ph.D. 1,2, H. Mason 1, & Paul R. Duberstein, Ph.D. 2 Department of Psychology,
Heart failure: The national burden AHA. Heart disease and stroke statistics–2005 update. Koelling TM et al. Am Heart J. 2004;147:74-8. VBWG Affects 1 million.
Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy JOINT SYMPOSIUM WITH JACCT - Bologna, 25/9/2008.
Heart rate in heart failure: Heart rate in heart failure: risk marker or risk factor? A subanalysis of the SHIFT trial on behalf of the Investigators M.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
The Many Moods of Heart Failure Sue Wingate PhD, RN Nurse Practitioner Gaithersburg MD.
CoRPS Center of Research on Psychology in Somatic diseases Cardiac Psychology: A match made in heaven for patients Susanne S. Pedersen, Professor of Cardiac.
CoRPS Center of Research on Psychology in Somatic diseases Positive and negative emotions and heart disease Susanne S. Pedersen, Professor of Cardiac Psychology.
CoRPS Center of Research on Psychology in Somatic diseases Patients with an ICD Susanne S. Pedersen, Professor of Cardiac Psychology.
CoRPS Center of Research on Psychology in Somatic diseases Type D personality as a risk factor for adverse vascular outcomes in diabetes patients: A role.
Adapted from Angiolillo DJ et al. Am J Cardiol. 2006;97: Individual Response Variability to Dual Antiplatelet Therapy in the Steady State Phase of.
Increased Patient Device Concerns But Not General Anxiety in Patients with a Secondary Indication for the ICD Susanne S. Pedersen, Professor of Cardiac.
CoRPS Center of Research on Psychology in Somatic diseases Poor health status in implantable cardioverter defibrillator patients: Shock, patient pre implantation.
CoRPS Center of Research on Psychology in Somatic diseases Tilburg University The Netherlands Predictors of posttraumatic stress (PTSD) 18 months post.
CoRPS Center of Research on Psychology in Somatic diseases Type D personality & haemoglobin in CHF Nina Kupper PhD Aline Pelle PhD Balázs M. Szabó MD PhD.
CoRPS Disclosures None. CoRPS Center of Research on Psychology in Somatic diseases Impact of psychological profile in heart failure patients Susanne S.
Type D Personality and Chronic Kidney Disease as Predictors of Pro- and Anti- Inflammatory Cytokine Levels in Heart Failure Interleukin-6 (IL-6), tumor.
CoRPS Center of Research on Psychology in Somatic diseases Inflammation, Mediation and Type D personality Multiple inflammatory biomarkers as mediators.
Individual differences in cardiovascular reactivity to physical and mental challenge tasks Center of Research on Psychology in Somatic diseases Dr. Nina.
The effects of mindfulness meditation training on Type D personality Center of Research on Psychology in Somatic diseases Dr. Nina Kupper Dr. Sietze Graafsma.
The Two Sides of Stress in the Workplace Positive and Incentivising or Negative and Oppressive?
Management Strategies for Post-Intervention in Patients with CAD VBWG.
Correlates of Patient Acceptance of the Cardioverter-Defibrillator: Cross-validation of the Florida Patient Acceptance Survey in Danish Patients Correlates.
CoRPS Center of Research on Psychology in Somatic diseases Brief Depression Screening with the PHQ-2 Predicts Poor Prognosis following PCI with Drug-Eluting.
CoRPS Center of Research on Psychology in Somatic diseases Depression is associated with a 2-fold independent risk of mortality in implantable cardioverter.
CoRPS Center of Research on Psychology in Somatic diseases ICD patients with anxiety: what to do? Susanne S. Pedersen, Professor of Cardiac Psychology.
Screening for CAD Nuclear Medicine prospective S.R.Zakavi,MD,IBNM Nuclear Medicine Research Center Mashhad University of Medical Sciences.
Presenter:Ibishi Nazmie MD, PhD University Clinical Center of Kosovo Clinic Of Psychiatry Mesic Srebrenka, Nebi Musliu.
Functional MR: When to Intervene
Revascularization in Patients With Left Ventricular Dysfunction:
TAVR in Patients with Chronic Lung Disease
The Association of Co-Morbid Symptoms of Depression and Anxiety With All-Cause Mortality in Patients With Heart Failure Abdullah S. Alhurani, PhDc, MSN,
by Johan Denollet, Angélique A. Schiffer, and Viola Spek
The percentage of subjects with de novo development of renal function impairment (GFR
Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.
Systolic Heart failure treatment with the If inhibitor ivabradine Trial Effect of ivabradine on recurrent hospitalization for worsening heart failure:
Baseline Characteristics by hs-CRP
Presentation transcript:

Johan Denollet, PhD the heart failure patient ? Why is a dedicated cardiologist not sufficient for The Netherlands

Dutch Heart Foundation, 2005 Dutch Heart Foundation, 2005 Chronic Heart Failure (CHF) Emerging epidemic Prevalence: cases Incidence: cases in the Netherlands

Type D Personality Type D Personality Personality and Prognosis Personality and Prognosis Personality and QoL Personality and QoL Potential mechanisms Potential mechanisms Type D Personality Type D Personality Personality and Prognosis Personality and Prognosis Personality and QoL Personality and QoL Potential mechanisms Potential mechanisms Personality & CHF: Overview

Type D Personality Type D Personality Personality and Prognosis Personality and Prognosis Personality and QoL Personality and QoL Potential mechanisms Potential mechanisms Type D Personality Type D Personality Personality and Prognosis Personality and Prognosis Personality and QoL Personality and QoL Potential mechanisms Potential mechanisms Personality & CHF: Overview

Negative Affectivity: tendency to Negative Affectivity: tendency to experience negative emotions experience negative emotions (Watson & Pennebaker, 1989) Negative Affectivity: tendency to Negative Affectivity: tendency to experience negative emotions experience negative emotions (Watson & Pennebaker, 1989) What is Type D Personality ?

Negativity Negativity HiLo

Negative Affectivity: tendency to Negative Affectivity: tendency to experience negative emotions experience negative emotions (Watson & Pennebaker, 1989) Social Inhibition: tendency to Social Inhibition: tendency to inhibit emotions and behaviors inhibit emotions and behaviors in social interaction in social interaction (Asendorpf, 1993) (Asendorpf, 1993) Negative Affectivity: tendency to Negative Affectivity: tendency to experience negative emotions experience negative emotions (Watson & Pennebaker, 1989) Social Inhibition: tendency to Social Inhibition: tendency to inhibit emotions and behaviors inhibit emotions and behaviors in social interaction in social interaction (Asendorpf, 1993) (Asendorpf, 1993) What is Type D Personality ?

Negativity Negativity Hi Inhibition HiLo Lo Other Type D

What is Type D Personality ? Negative Affectivity I am often down in the dumps I am often down in the dumps I often find myself worrying about something I often find myself worrying about something I am often irritated I am often irritated Social Inhibition I find it hard to start a conversation I find it hard to start a conversation I am a closed kind of person I am a closed kind of person I often feel inhibited in social interactions I often feel inhibited in social interactions Negative Affectivity I am often down in the dumps I am often down in the dumps I often find myself worrying about something I often find myself worrying about something I am often irritated I am often irritated Social Inhibition I find it hard to start a conversation I find it hard to start a conversation I am a closed kind of person I am a closed kind of person I often feel inhibited in social interactions I often feel inhibited in social interactions

What is Type D Personality ? Negative Affectivity I am often down in the dumps I am often down in the dumps I often find myself worrying about something I often find myself worrying about something I am often irritated I am often irritated Social Inhibition I find it hard to start a conversation I find it hard to start a conversation I am a closed kind of person I am a closed kind of person I often feel inhibited in social interactions I often feel inhibited in social interactions Negative Affectivity I am often down in the dumps I am often down in the dumps I often find myself worrying about something I often find myself worrying about something I am often irritated I am often irritated Social Inhibition I find it hard to start a conversation I find it hard to start a conversation I am a closed kind of person I am a closed kind of person I often feel inhibited in social interactions I often feel inhibited in social interactions

Denollet, Psychosom Med, 2005; 67: Denollet, Psychosom Med, 2005; 67: DS 14 0=FALSE 1=RATHER FALSE 2=NEUTRAL 3=RATHER TRUE 4=TRUE _____________________________________________________________________________ 1 I make contact easily when I meet people - - I often make a fuss about unimportant things I often talk to strangers  I often feel unhappy  I am often irritated  I often feel inhibited in social interactions I take a gloomy view of things  I find it hard to start a conversation  I am often in a bad mood  I am a closed kind of person  I would rather keep other people at a distance I often find myself worrying about something I am often down in the dumps  When socializing, I don’t find the right things to talk about _____________________________________________________________________________

Down in the dumps Feeling blue Angry Worried Bad mood Unhappy The burden of negative emotions and inhibition Type D Type D ? No!! I do not want to share my emotions with others… What is Type D Personality ?

Type D Personality Type D Personality Personality and Prognosis Personality and Prognosis Personality and QoL Personality and QoL Potential mechanisms Potential mechanisms Type D Personality Type D Personality Personality and Prognosis Personality and Prognosis Personality and QoL Personality and QoL Potential mechanisms Potential mechanisms Personality & CHF: Overview

23/85 15/218 p<.0001 Denollet et al., Lancet, 1996; 347: Denollet et al., Lancet, 1996; 347: Death 6-10 year FU CAD: Risk of Cardiac Events

Death/MI 5 year FU 16/86 6/206 23/85 15/218 p<.0001 Denollet, Vaes & Brutsaert, Circulation, 2000; 102: Denollet, Vaes & Brutsaert, Circulation, 2000; 102: Death 6-10 year FU CAD: Risk of Cardiac Events

0% 2% 4% 6% Non-Type D Type D 0 m3 m6 m9 months Type D Non-Type D Numbers at risk RESEARCH Trial Erasmus Medical Center Rotterdam Cumulative proportion at risk (%) 5.31 HR = 5.31 * [ CI ].002 p =.002 Pedersen SS et al., J Am Coll Cardiol, 2004; 44: Pedersen SS et al., J Am Coll Cardiol, 2004; 44: Post-PCI Patients: Death / MI

Denollet & Brutsaert, Circulation, 1998; 97: Denollet & Brutsaert, Circulation, 1998; 97: HR = 4.7 Heart Failure: Death / MI 9y FU

OR= 3.75 p=.009 p=.009 LVEF >50% Denollet et al., in preparation Denollet et al., in preparation Death / MI ( n = 103) 6.1 yrs FU ( n = 1068) LVEF <40% LVEF 40-50% OR= 4.89 p=.004 p=.004 OR= 2.90 p<.0001 p<.0001

Type D Personality Type D Personality Personality and Prognosis Personality and Prognosis Personality and QoL Personality and QoL Potential mechanisms Potential mechanisms Type D Personality Type D Personality Personality and Prognosis Personality and Prognosis Personality and QoL Personality and QoL Potential mechanisms Potential mechanisms Personality & CHF: Overview

Aquarius, Denollet et al., Am J Cardiol, 2005; 96: Aquarius, Denollet et al., Am J Cardiol, 2005; 96: P=.0001 PAD patients Healthy subjects P=.0001 Type D & PAD: Poor QoL

Independent predictors in multivariable analysis Type D personality3.04[ ]0.002 Diabetes mellitus Diabetes mellitus2.75[ ]0.012 Male sex0.62[ ]0.18 Age1.02[ ]0.25 Multi-vessel disease1.34[ ]0.39 Sirolimus - eluting stent 0.72[ ]0.35 Variable OR [95% CI] p Pedersen, et al., Am Heart J, 2006; 151: 367.e1-367.e6 Post-PCI: Depression (1y FU)

Type D (n = 38) Non-Type D (n =46) Schiffer et al., Eur J Cardiovasc Prev Rehabil, 2005; 12: Heart Failure: Impaired QoL

Schiffer et al., Eur J Cardiovasc Prev Rehabil, 2005; 12: Heart Failure: Impaired QoL

Schiffer et al., Eur J Cardiovasc Prev Rehabil, 2005; 12: Heart Failure: Impaired QoL

Pedersen et al., Psychosom Med, 2004; 66: Pedersen et al., Psychosom Med, 2004; 66: p <.001 ICD: Anxiety & Depression

Non-Type D p=.001 p=.006 Type D Pedersen & Denollet, Eur J Cardiovasc Prev Rehabil 2003; 10: CABG/PCI: Symptoms of Fatigue

Large effect Moderate effect Small effect Type D Effect Gender Effect CABG/PCI: Gender versus Type D Fatigue Pedersen & Denollet, Eur J Cardiovasc Prev Rehabil 2003; 10: 241-8

Type D Personality Type D Personality Personality and Prognosis Personality and Prognosis Personality and QoL Personality and QoL Potential mechanisms Potential mechanisms Type D Personality Type D Personality Personality and Prognosis Personality and Prognosis Personality and QoL Personality and QoL Potential mechanisms Potential mechanisms Personality & CHF: Overview

Behavioral Pathway: Behavioral Pathway: failure to quit smoking failure to quit smoking poor compliance with treatment poor compliance with treatment Behavioral Pathway: Behavioral Pathway: failure to quit smoking failure to quit smoking poor compliance with treatment poor compliance with treatment Potential Pathways

Behavioral Pathway: Behavioral Pathway: failure to quit smoking failure to quit smoking poor compliance with treatment poor compliance with treatment inadequate consultation behavior inadequate consultation behavior Behavioral Pathway: Behavioral Pathway: failure to quit smoking failure to quit smoking poor compliance with treatment poor compliance with treatment inadequate consultation behavior inadequate consultation behavior Potential Pathways

Consultation behavior in CHF Consulting doctor/nurse for symptoms that are relevant to CHF (Ekman et al., 2005)Consulting doctor/nurse for symptoms that are relevant to CHF (Ekman et al., 2005)

Consultation behavior in CHF Consulting doctor/nurse for symptoms that are relevant to CHF (Ekman et al., 2005)Consulting doctor/nurse for symptoms that are relevant to CHF (Ekman et al., 2005) Influenced by the patient’s appraisal of the seriousness of the symptomsInfluenced by the patient’s appraisal of the seriousness of the symptoms

Consultation behavior in CHF Consulting doctor/nurse for symptoms that are relevant to CHF (Ekman et al., 2005)Consulting doctor/nurse for symptoms that are relevant to CHF (Ekman et al., 2005) Influenced by the patient’s appraisal of the seriousness of the symptomsInfluenced by the patient’s appraisal of the seriousness of the symptoms Influenced by the patient’s attitudes to help seeking & disclosing personal feelingsInfluenced by the patient’s attitudes to help seeking & disclosing personal feelings

- 178 CHF outpatients, LVEF ≤ 40% -European Heart Failure Self-Care Behaviour Scale (Jaarsma et al., 2003) -4-item subscale: I contact my doctor or nurse, if: My feet/legs become more swollen than usual My shortness of breath increases I experience increased fatigue I gain 2 kg in 1 week Consultation behavior & CHF Schiffer, Denollet et al., Submitted for publication

- 178 CHF outpatients, LVEF ≤ 40% -European Heart Failure Self-Care Behaviour Scale (Jaarsma et al., 2003) -4-item subscale: I contact my doctor or nurse, if: I contact my doctor or nurse, if: My feet/legs become more swollen than usual My feet/legs become more swollen than usual My shortness of breath increases My shortness of breath increases I experience increased fatigue I experience increased fatigue I gain 2 kg in 1 week I gain 2 kg in 1 week Consultation behavior & CHF Schiffer, Denollet et al., Submitted for publication

(1) Type D patients experienced more cardiac symptoms than non-Type D ( OR = 6.4) symptoms than non-Type D ( OR = 6.4) (2) Type Ds more often appraised these symptoms as worrisome ( OR = 2.9) (3) Paradoxically, they were less likely to report their symptoms to their doctor/nurse ( OR = 2.7) Consultation behavior & CHF Schiffer, Denollet et al., Submitted for publication

(1) Type D patients experienced more cardiac symptoms than non-Type D ( OR = 6.4) (2) Type Ds more often appraised these symptoms as worrisome ( OR = 2.9) symptoms as worrisome ( OR = 2.9) (3) Paradoxically, they were less likely to report their symptoms to their doctor/nurse ( OR = 2.7) Consultation behavior & CHF Schiffer, Denollet et al., Submitted for publication

(1) Type D patients experienced more cardiac symptoms than non-Type D ( OR = 6.4) (2) Type Ds more often appraised these symptoms as worrisome ( OR = 2.9) (3) Paradoxically, they were less likely to report their symptoms to their doctor/nurse ( OR = 2.7) their symptoms to their doctor/nurse ( OR = 2.7) Consultation behavior & CHF Schiffer, Denollet et al., Submitted for publication

Consultation behavior & CHF Schiffer, Denollet et al., Submitted for publication p< % of the CHF patients who experienced symptoms but failed to consult were classified as Type D as compared to only 14% of the other patients Sympt -Sympt + Sympt + Sympt -Sympt + Sympt + Consult + Consult -

Denollet, Pedersen SS et al., Eur Heart J, 2006; 27: Denollet, Pedersen SS et al., Eur Heart J, 2006; 27: Modulating Effect of Inhibition

Behavioral Pathway: Behavioral Pathway: failure to quit smoking failure to quit smoking poor compliance with treatment poor compliance with treatment inadequate consultation behavior inadequate consultation behavior Direct, Physiological Pathway: Direct, Physiological Pathway: cortisol, stress hormones cortisol, stress hormones chronic low-grade inflammation chronic low-grade inflammation Behavioral Pathway: Behavioral Pathway: failure to quit smoking failure to quit smoking poor compliance with treatment poor compliance with treatment inadequate consultation behavior inadequate consultation behavior Direct, Physiological Pathway: Direct, Physiological Pathway: cortisol, stress hormones cortisol, stress hormones chronic low-grade inflammation chronic low-grade inflammation Potential Pathways

Behavioral Pathway: Behavioral Pathway: failure to quit smoking failure to quit smoking poor compliance with treatment poor compliance with treatment inadequate consultation behavior inadequate consultation behavior Direct, Physiological Pathway: Direct, Physiological Pathway: cortisol, stress hormones cortisol, stress hormones chronic low-grade inflammation chronic low-grade inflammation pro-inflammatory cytokines pro-inflammatory cytokines Behavioral Pathway: Behavioral Pathway: failure to quit smoking failure to quit smoking poor compliance with treatment poor compliance with treatment inadequate consultation behavior inadequate consultation behavior Direct, Physiological Pathway: Direct, Physiological Pathway: cortisol, stress hormones cortisol, stress hormones chronic low-grade inflammation chronic low-grade inflammation pro-inflammatory cytokines pro-inflammatory cytokines Potential Pathways

p=.005 p=.009 TNF -  sTNFR1sTNFR2 Denollet, Conraads et al., Brain, Behav & Immun, 2003; 17: Denollet, Conraads et al., Brain, Behav & Immun, 2003; 17: Type D & Cytokines in CHF ( n = 42)

Type D personality3.9[ ] Age >60 yrs2.3[ ]0.16 Male sex1.4[ ]0.66 LVEF1.1[ ]0.23 Ischemic heart failure1.5[ ]0.54 NYHA class III / IV 2.4[ ]0.13 Variable OR [95% CI] p Independent predictor sTNFR2 ( n = 91) Conraads, Denollet et al., Int J Cardiol, 2006; In Press Conraads, Denollet et al., Int J Cardiol, 2006; In Press

Type D personality3.9[ ] Age >60 yrs2.3[ ]0.16 Male sex1.4[ ]0.66 LVEF1.1[ ]0.23 Ischemic heart failure1.5[ ]0.54 NYHA class III / IV 2.4[ ]0.13 Variable OR [95% CI] p Independent predictor sTNFR2 ( n = 91) Conraads, Denollet et al., Int J Cardiol, 2006; In Press Conraads, Denollet et al., Int J Cardiol, 2006; In Press

Type D or Not Type D ?